ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 172599 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 172599; 2) Community: the network communities that were significantly associated with the response to NSC 172599; 3) Molecule: the relationships between components within communities and NSC 172599; 4) MDR: the compounds that were significantly associated with the NSC 172599.

NSC Compound Enrichment Correlation
NSC 625499 Antimony, mu-iododiiodo[mu-(4-thiomorpholinecarbodi- thioato-S(4),S(4')]bis(4-thiomorpholinecarbodithioato-S(4), S(4'))di- 0.0019278627680628 0.4128108
NSC 626876 2-Cyclopenten-1-one, 5-[(dimethylamino)methyl]-2-[2-[4- (2-methylpropyl)phenyl]propyl]-, hydrochloride 0.0019278627680628 0.40406474
NSC 716535 Null 0.0019278627680628 0.42675695
NSC 736443 7-fluoro-2-(2-furoyl)-3-trifluoromethylquioxaline 1,4-dioxide 0.0019278627680628 0.56140339
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.00206000157707806 0.34817191
NSC 34533 Fulcin 0.00206000157707806 0.26179582
NSC 529108 4-Fluoro-D,L-tryptophan 0.00206000157707806 0.22224477
NSC 602313 Null 0.00206000157707806 0.35867848
NSC 609815 2-Benzoylaminobenzamide, N-thiazol-2-yl- 0.00206000157707806 0.43184131
NSC 656204 Discorhabdin G 0.00206000157707806 0.28155048
Total:177  Current:29    [First] [Prev] [Next] [Last]